Rezolute Inc (RZLT)
2.66
+0.06
(+2.31%)
USD |
NASDAQ |
Apr 26, 16:00
2.65
-0.01
(-0.38%)
After-Hours: 20:00
Rezolute Price to Book Value: 1.149 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 1.149 |
April 25, 2024 | 1.123 |
April 24, 2024 | 1.248 |
April 23, 2024 | 1.236 |
April 22, 2024 | 1.529 |
April 19, 2024 | 1.482 |
April 18, 2024 | 1.426 |
April 17, 2024 | 1.400 |
April 16, 2024 | 1.469 |
April 15, 2024 | 1.330 |
April 12, 2024 | 1.166 |
April 11, 2024 | 1.123 |
April 10, 2024 | 1.045 |
April 09, 2024 | 1.08 |
April 08, 2024 | 1.093 |
April 05, 2024 | 1.020 |
April 04, 2024 | 0.9979 |
April 03, 2024 | 1.028 |
April 02, 2024 | 0.9893 |
April 01, 2024 | 1.045 |
March 28, 2024 | 1.102 |
March 27, 2024 | 0.9677 |
March 26, 2024 | 0.9158 |
March 25, 2024 | 0.8165 |
March 22, 2024 | 0.864 |
Date | Value |
---|---|
March 21, 2024 | 0.8294 |
March 20, 2024 | 0.8251 |
March 19, 2024 | 0.8208 |
March 18, 2024 | 0.7733 |
March 15, 2024 | 0.7689 |
March 14, 2024 | 0.7862 |
March 13, 2024 | 0.8294 |
March 12, 2024 | 0.8424 |
March 11, 2024 | 0.864 |
March 08, 2024 | 0.8208 |
March 07, 2024 | 0.7819 |
March 06, 2024 | 0.7754 |
March 05, 2024 | 0.7689 |
March 04, 2024 | 0.8294 |
March 01, 2024 | 0.7776 |
February 29, 2024 | 0.7128 |
February 28, 2024 | 0.6998 |
February 27, 2024 | 0.7301 |
February 26, 2024 | 0.7085 |
February 23, 2024 | 0.743 |
February 22, 2024 | 0.6912 |
February 21, 2024 | 0.635 |
February 20, 2024 | 0.6264 |
February 16, 2024 | 0.5832 |
February 15, 2024 | 0.5227 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2824
Minimum
Nov 29 2023
75.17
Maximum
Aug 01 2019
5.678
Average
1.812
Median
May 31 2022
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 1.739 |
Palatin Technologies Inc | -- |
iBio Inc | 0.6668 |
Theriva Biologics Inc | 0.1946 |
Oragenics Inc | 2.929 |
Price to Book Value Related Metrics
Price | 2.66 |
Earnings Yield | -41.35% |
Market Cap | 105.40M |